Together, evidence is mounting that caudatin has a dual role in regulating the mTORC1/NF-κB signalling axis to maintain bone homeostasis and should be considered a viable treatment option for osteoporosis (Figure 4A). This evidence concerns the gene NFKB1 and osteoporosis.